GeoVax Labs Inc. (GOVX.OB) Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
1/10/2013 8:57:28 AM
More...
|
GeoVax Labs Inc. (GOVX.OB) to Present at Fifth Annual LD Micro Conference
11/29/2012 9:09:28 AM
More...
|
GeoVax Labs Inc. (GOVX.OB) Reports 2012 Second Quarter Financial Results
8/13/2012 8:57:24 AM
More...
|
GeoVax, Inc. to Attend Biotechnology Industry Organization (BIO) International Convention June 18-21 in Boston
6/11/2012 9:44:07 AM
More...
|
GeoVax, Inc. Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
12/7/2010 7:20:26 AM
More...
|
GeoVax, Inc. Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11/5/2010 6:57:09 AM
More...
|
GeoVax, Inc. Presents at AIDS Vaccine 2010 Conference in Atlanta
10/1/2010 9:31:05 AM
More...
|
GeoVax, Inc. to Present at HIV/AIDS Vaccine Symposium at New York Academy of Sciences on May 19
5/17/2010 11:47:15 AM
More...
|
GeoVax, Inc. to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
8/26/2009 11:39:41 AM
More...
|
GeoVax, Inc. Update Provided at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2009
2/12/2009 10:46:32 AM
More...
|
|